Release of cytochrome c from isolated mitochondria by etoposide

Jung-Hee Park1, Tae-Hyoung Kim

  • 1Department of Biochemistry, Chosun University School of Medicine, Dong-Gu, Gwangju, Korea.

Insights

Etoposide induces tumor cell death independently of the p53 tumor suppressor gene. This occurs through direct mitochondrial dysfunction, offering a p53-independent pathway for chemotherapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The tumor suppressor gene p53 and its targets regulate chemotherapy efficacy.
  • Some chemotherapeutic agents induce cell death in p53-deficient tumor cells, suggesting p53-independent pathways.
  • Understanding these pathways is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To investigate the role of p53 in etoposide- and 5'-FU-induced cell death.
  • To elucidate the mechanism of p53-independent cell death induced by etoposide.

Main Methods:

  • Comparison of etoposide and 5'-FU efficacy in p53-deficient HCT 116 cells.
  • Analysis of cytochrome c release from isolated mitochondria upon etoposide treatment.
  • Assessment of mitochondrial swelling in response to etoposide.

Main Results:

  • Etoposide induced significant cell death in p53-deficient cells, similar to p53-expressing cells.
  • 5'-FU-mediated cell death was highly dependent on functional p53.
  • Etoposide triggered cytochrome c release from mitochondria without causing swelling, indicating direct mitochondrial dysfunction.
  • This mitochondrial dysfunction occurred irrespective of p53 status.

Conclusions:

  • Etoposide induces cell death through a p53-independent pathway involving direct mitochondrial dysfunction.
  • This mechanism may explain how certain chemotherapeutic agents overcome p53 deficiency in tumors.
  • Targeting mitochondrial pathways could be a strategy for treating p53-deficient cancers.